期刊文献+

别嘌醇、丙磺舒以及两者联用对马兜铃酸肝肾损害保护作用研究 被引量:2

Protective Effect of Allopurinol or Probenecid Alone and Their Combination against Liver and Kidney Toxicity Induced by Aristolochic Acid in Mice
下载PDF
导出
摘要 目的:探讨别嘌醇(A)、丙磺舒(P)以及两者联用对马兜铃酸肝肾毒性的防治作用,并初步探讨其作用机制。方法:将雄性ICR小鼠随机分为5组:正常对照组(C组)、关木通模型组(M组)、别嘌醇组(A组)、丙磺舒组(P组)、别嘌醇+丙磺舒组(A+P组)。C组灌胃等体积饮用水,后4组灌胃给予7g·kg-1·d-1的关木通水煎剂,给药4天后停药3天,持续4周;各给药组从第3周起在给予造模药的同时灌胃给予相应药物即A(70mg·kg-1·d-1)、P(360mg·kg-1·d-1)、A(70mg·kg-1·d-1)+P(360mg·kg-1·d-1)。实验结束时,测定小鼠血清肌酐(Cr)、尿素氮(BUN)、谷丙转氨酶(ALT)、谷草转氨酶(AST)水平,并记录左肾、左睾系数。结果:与M组相比,各给药组均能显著降低血清Cr、BUN、ALT、AST水平,其中A+P组各指标改善作用最为显著。结论:A和P对马兜铃酸所致肝肾损伤都具有保护作用,且两药联用的效果优于两药单独应用。 Objective : To observe the protective effect of allopurinol or probenecid alone and their combination against liver and kid- ney toxicity induced by aristolochic acid in mice, and to explore the related mechanisms preliminarily. Methods : Male ICR mice were randomly divided into 5 groups including control (C) group, model (M) group, allopurinol (A) group, probenecid (P) group and al- lopurinol+ probenecid (A+P) group. The mice in control group and the other groups were given distilled water and Caulis Aristolo- chiae Manshuriensis (7g. kg -1. d -1 , the first four days per week and lasting for four weeks). Two weeks later, A group, P group and A+P group were treated with intragastric administration of A 70mg · kg-1 · d-1 , P 360mg · kg · -1 d -1 , A 70mg · kg -1 d -1+P 360mg · kg · d -1 respectively besides Caulis Aristolochiae Manshuriensis. At the end of the experiment, the contents of crea- tine (Cr), urea nitrogen (BUN), alanine transaminase (ALT) and aspartate aminotransferase (AST) in blood serum were deter- mined. The kidney and testis coefficient were recorded as well. Results:Compared with M group, the contents of serum Cr, BUN, AI.T, AST of mice in A group, P group and A+P group were all significantly reduced. The biochemical indicators of mice in A4-P group were improved the most significantly. Conclusion:Both allopurinol and probenecid have protective effect against the damage to liver and kidney induced by aristolochie acid and the combination therapy is prior to single therapy.
出处 《亚太传统医药》 2013年第12期6-8,共3页 Asia-Pacific Traditional Medicine
关键词 马兜铃酸 别嘌醇 丙磺舒 黄嘌呤氧化酶 有机阴离子转运蛋白 Aristolochic Acid Allopurinol Probenecid Xanthine Oxidase Organic Anion Transporters
  • 相关文献

参考文献13

  • 1HASHIMOTO K, HIGUCHI M, MAKINO B, ct al. Quan titative analysis of aristolochic acids, toxic compounds, con- tained in some medicinal plants [J]. J Ethnopharmacol, 1999, 64 (2) :185-189.
  • 2IOSET JR, RAOELISON GE, HOSTETTMANN K. Detec- tion of aristolochie acid in Chinese phytomedicines and dietary supplements used as slimming regimens[J]. Food and Chem Toxicol, 2003,41(1) :29-36.
  • 3STIBOROVA M, FREI E, BREUER A, et al. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephrop athy [J]. Exp Toxicol Pathol, 1999, 51(4-5) :421 427.
  • 4CHAN W, CUI L, XU G, et al. Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry[J]. Rapid Com- mun Mass Speetrom, 2006, 20(11) :1755-1760.
  • 5SCHMEISER HH, FREI E, WIESSLEIR M, et al. Compar ison of DNA adduct formation by aristolochic acids in various activation systems by 32P post-lahetiing., evidence for reduc- tire activation by peroxidases :dl. Carcinogenesis, i997, 18 (5) : 1055-1062.
  • 6SCHMEISER HH, SCHOEPE KB, WIESSI.ER M. DNA adduct formation of aristolochic acid I and II in vitro and in vi vo [J]. Carcinogenesis, 1988,9 (2) : 297-303.
  • 7STIBOROVA M, SOPKO B, HODEK P, et al. The binding of aristolochie acid I to the active site of human cytoehromes P450 1A1 and 1A2 explains their potential to reductively acti- vate this human carcinogen[J]. Cancer Lctt, 2005, 229(2): 193 2O4.
  • 8STIBOROVA M, FRE1 E, BREUER A, et al. Evidence for reductive activation of carcinogenic aristoloehic acids by pros taglandin H synthase-32P postlabeling analysis of DNA ad duct formation [J]. Mutat Res, 2001, 493(1 2):149-160.
  • 9BAKHIYA N, ARLT VM, BAHN A, et al. Molecular evi- dence for an involvement of organic anion transporters (OATs) in aristolochic acid netropathy [J]. Toxicology, 2009,264 (1-2) : 74-79.
  • 10王艳艳,谌贻璞,芮宏亮.有机阴离子转运蛋白介导马兜铃酸进入肾小管上皮细胞[J].中国医学科学院学报,2009,31(4):476-480. 被引量:3

二级参考文献11

共引文献2

同被引文献28

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部